| 2024 | Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial | DIABETES OBESITY & METABOLISM |
| 2024 | Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | SGLT2 and DPP4 inhibitors improve Alzheimer's disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model
| BIOMEDICINE & PHARMACOTHERAPY |
| 2023 | Lean or non-obese nonalcoholic fatty liver disease patients: Are they really lean?
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells
| JOURNAL OF BIOLOGICAL CHEMISTRY |
| 2023 | Comparisons of the prediction models for undiagnosed diabetes between machine learning versus traditional statistical methods
| SCIENTIFIC REPORTS |
| 2023 | Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2023 | Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2023 | Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons
| NATURE COMMUNICATIONS |
| 2023 | β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 8 months | DIABETES & METABOLISM |
| 2023 | O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis
| FRONTIERS IN IMMUNOLOGY |
| 2023 | Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice
| DIABETOLOGIA |
| 2023 | Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial | DIABETES OBESITY & METABOLISM |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
| 2023 | Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2023 | Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial | EUROPEAN HEART JOURNAL |
| 2023 | Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
| DIABETES & METABOLISM JOURNAL |
| 2023 | Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008–2018
| NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES |
| 2022 | Effect of low skeletal muscle mass and sarcopenic obesity on chronic kidney disease in patients with type 2 diabetes | OBESITY |
| 2022 | Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study
| JOURNAL OF DIABETES INVESTIGATION |
| 2022 | Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
| YONSEI MEDICAL JOURNAL |
| 2022 | Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
| BMC MEDICINE |
| 2022 | The effects of the voglibose on non-alcoholic fatty liver disease in mice model
| SCIENTIFIC REPORTS |
| 2022 | Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice
| BIOMEDICINES |
| 2022 | Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
| DIABETES & METABOLISM JOURNAL |
| 2022 | Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function
| SCIENTIFIC REPORTS |
| 2022 | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome | HEPATOLOGY |
| 2022 | Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
| YONSEI MEDICAL JOURNAL |
| 2022 | Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial
| CLINICAL JOURNAL OF PAIN |
| 2022 | Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
| BIOMEDICINES |
| 2022 | The predicting value of resting heart rate to identify undiagnosed diabetes in Korean adult: Korea National Health and Nutrition Examination Survey
| EPIDEMIOLOGY AND HEALTH |
| 2022 | Inhibition of CXXC5 function reverses obesity-related metabolic diseases
| CLINICAL AND TRANSLATIONAL MEDICINE |
| 2022 | Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2022 | Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular disease | HEART |
| 2022 | Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
| DIABETES & METABOLISM JOURNAL |
| 2022 | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
| BMC MEDICINE |
| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
| JAMA NETWORK OPEN |
| 2022 | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2022 | Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People | HYPERTENSION |
| 2021 | The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
| Endocrinology and Metabolism(대한내분비학회지) |
| 2021 | Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2021 | Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes | DIABETES RESEARCH AND CLINICAL PRACTICE |
http://orcid.org/0000-0002-6219-4942
(56424219700)
